1. business and industrial
2. business operations
3. business plans

NPPG 20th Annual
Conference and
Exhibition
7-9 November 2014
East Midlands Conference Centre
Nottingham
Delegate Information
The Neonatal and Paediatric Pharmacists Group (NPPG) are pleased to invite you
to the 20th NPPG Annual Conference and Exhibition
NPPG are excited to be holding our annual conference in the East Midland’s Conference Centre in Nottingham this year. The
programme will include keynote speeches on practical issues such as Brain Tumour management and how we manage children’s pain
without codeine, as well as more strategic issues for the NPPG.
There will be a range of parallel & workshop sessions aimed at foundation, intermediate and advanced level practitioners. Clinical topics
will include drug management of GORD, Antibiotics, Renal, Metabolic and Liver disease, Poisoning and TPN. Non-clinical sessions
focusing on NHS Commissioning, Self/parent/carer administration of medicine, leadership and consultation skills will help those with
more senior roles within paediatrics to improve the services provided to children and their families
Alongside these sessions there will be discussion groups, a poster exhibition, short paper presentations and many opportunities to
“network” with colleagues from around the UK and further afield. We hope you will also enjoy the social aspects of conference both at
the dinner and in the many informal meeting areas in the conference centre.
The NPPG look forward to welcoming everyone to Nottingham.
Andrew Wignell
Senior Paediatric Pharmacist, Nottingham University Hospital NHS
Keynote speakers
9.30am
10.05am
Dr Helen Sammons
Associate Professor of Child Health, University
of Nottingham, and Consultant Paediatrician,
Derbyshire Children’s Hospital
Keynote 1 - Audacious strategies for
the NPPG
Professor Malcolm B R Partridge
Chief Pharmacist & Clinical Director of
Medicines Management, Faculty of Medicine &
Health Sciences, University of Nottingham
Malcolm Partridge registered as a pharmacist
in 1975 after graduating in Leicester. He went
on to establish Leicester’s first resident 24
hour pharmacy scheme and was their first staff pharmacist for
clinical pharmacy service development. During this time he was
successful in obtaining an MSc in Pharmacotherapeutics. In
1982 he took time out to undertake a research project over 3
years in which he developed a novel in vitro cytotoxicity test for
new anticancer agents and this led to his PhD award in 1987. He
moved to Liverpool John Moores University in 1985 to become
their first teacher–practitioner during which time he developed an
interest not only in Education and Training but also in paediatrics
at the Royal Liverpool Children’s Hospital - Alder Hey which was
his clinical practice base.
In 1994 along with others he became a founder member of the
Neonatal and Paediatric Pharmacists Group and was their Chairman
for 4 years. NPPG now has an international membership and was
co-author for the formulary “Medicines for Children”. This ultimately
led to the production of the BNF for Children.
Following a move to Derby in 1996 he helped establish a new MSc
in Clinical Pharmacy with the University of Derby before becoming
Chief Pharmacist at Derby City Hospital and Derbyshire Children’s
Hospital. He was appointed Chief Pharmacist at the Queen’s
Medical Centre University Hospital, Nottingham in May 1999 where
he has taken a leading role in the development of systems for
medicines management.
He has lectured on this subject and on Medication Errors to
a wide audience both in the UK and abroad. He regularly provides
consultancy on the introduction of new drugs into clinical practice.
More recently the Trust appointed him Clinical Director for
Medicines Management.
In March 2005, Malcolm Partridge was appointed “Professor of
Medicines Management and Hospital Pharmacy” by the University
of Nottingham as a compliment to his role as Chief Pharmacist at
Queen’s Medical Centre.
In October 2007 he was appointed Head of Pharmacy and
Medicines Management at the new Nottingham University Hospitals
NHS Trust now the 4th largest teaching hospital in the UK.
Keynote 2 - Sedation and Pain:
Is there life after Codeine?
Dr Helen Sammons is Associate Professor of
Child Health at the University of Nottingham and
a Consultant Paediatrician at the Derbyshire
Children’s Hospital.
She was the first paediatrician formally trained in Paediatric Clinical
Pharmacology in the UK, through the Royal College of Paediatrics
in Child Health (RCPCH). Her research interests include clinical
drug trials in children and neonates, safe and effective prescribing
and the ethics of paediatric clinical trials. Dr Sammons is vice chair
of the Derby Research Ethics Committee and the RCPCH/NPPG
Joint Medicines Committee. Her published work includes the ethical
issues surrounding clinical trials and the European Legislation,
safety in clinical trials, sedation for diagnostic imaging and
prescribing assessments.
12.05pm
Keynote 3 – Brain tumour management
and recent medical innovations
Dr David Walker
Professor of Paediatric Oncology, Children’s
Brain Tumour Research Centre, Faculty of
Medicine and Health Sciences, University
of Nottingham
David Walker is Professor of Paediatric Oncology
and co-director, with Professor Richard Grundy,
of the Children’s Brain Tumour Research Centre, launched by
the University of Nottingham’s Jubilee Appeal in 1997. Since
being appointed at the University of Nottingham in 1990, he led
the development of the clinical service for children with cancer in
Nottingham as part of the Mid-Trent region until 2006. Academically,
he led the undergraduate fourth year course in paediatrics for seven
years within the University of Nottingham, leading its revision under
the General Medical Council document ‘Tomorrow’s Doctors’. His
research interests have a broad spectrum within paediatric oncology
with a particular interest in brain tumours, health outcomes,
functional imaging, drug delivery, clinical trials and adolescent
medicine. He leads the current national “Headsmart – Be brain
tumour aware” campaign launched in June 2011.
Programme highlights
Plenary sessions
Saturday 8 November
Keynote 1 – Audacious strategies for the NPPG
Keynote 2 – Sedation and Pain: Is there a life after Codeine?
Debate – Should the NPPG join the RPS?
Sunday 9 November
Keynote 3 – Brain tumour management and recent medical innovations
Plus your choice of parallel sessions and workshops covering a variety of topics
F
FOUNDATION
I
INTERMEDIATE
A
ADVANCED
F
Management of GORD
Antibiotic choice in hospital infections
Do you need a pharmacist when
there is Toxbase?
Consultation skills
Neonatal TPN
I
High Cost Medicines
Self/Parent/Carer Administration
Paediatric Renal Disease
Inherited Metabolic Disorders
Assessment of liver function
A
Future pharmacy leaders
F
F
F
F
I
I
I
I
Programme
Friday 7 November
6.00pm
Registration, welcome refreshments, exhibition & posters
7.00pm
Discussion groups (45 minutes in length, repeated at 7.50pm)
1.
Medicines information update
Rowena McArtney, Senior Information Pharmacist, Cardiff & Vale University Health Board
2.
Update on national developments and initiatives in paediatric pharmacy 2014
Steve Tomlin, Consultant Pharmacist - Children’s Services, Guy’s & St Thomas’ NHS Foundation Trust
3.
Developing MEDUSA for paediatrics
Nanna Christiansen, Lead Clinical Pharmacist – Paediatrics, Barts Health NHS Trust and Jenny Haylor, Paediatric
Pharmacist - HAGM/ONC, University Hospital Bristol
4.
RPS Faculty
Chloe Benn, Principal Pharmacist, Royal Free London NHS Foundation Trust
5.
Medicines for Children Research Network (MCRN) – how can we support you?
Professor James McElnay, Queen’s University Belfast (Invited)
7.50pm
Discussion groups repeated as above
8.25pm
Wine reception, supper and networking
NPPG 20th Annual Conference and Exhibition
7-9 November 2014 East Midlands Conference Centre, Nottingham
Saturday 8 November
8.45am
Registration, refreshments, exhibition & posters
8.15am
First timer’s breakfast
9.25am
Welcome and opening address from Chair
Penny North-Lewis, Chair, NPPG
9.30am
Keynote 1 - Audacious strategies for the NPPG
Professor Malcolm B R Partridge, Chief Pharmacist & Clinical Director of Medicines Management, Faculty of
Medicine & Health Sciences, University of Nottingham
10.05am
Keynote 2 - Sedation and Pain: Is there life after Codeine?
Dr Helen Sammons, Associate Professor of Child Health, University of Nottingham, and Consultant Paediatrician,
Derbyshire Children’s Hospital
10.40am
Refreshments, exhibition & posters
11.15am
Overview of the short paper selection process
Sharon Conroy, Lecture in Paediatric Clinical Pharmacy, Academic Division of Child Health, University of Nottingham,
Derbyshire Children’s Hospital
11.20am
Submitted papers in the spotlight (1)
Chair Dr Graham March, Special Products Ltd
12.10pm
Debate – Should the NPPG join the RPS?
The Big Debate: The RPS Faculty is proposing affiliation with the main pharmacy member groups in order to unite us
all to support the advancement and development of pharmacists in all specialities and sectors.
We will hold a debate on the benefits and risks of affiliation for NPPG and our members, to help NPPG members
understand what this could offer and mean for them.
12.50pm
Lunch, exhibition & posters
1.50pm
Submitted papers in the spotlight (2)
2.40pm
Parallel sessions
(50-minutes long, choose to attend one)
F A/B1
Diagnosis and management of Gastro-oesophageal reflux disease GORD in children
Arun Urs, Consultant Paediatric Gastroenterologist, Sheffield Children’s Hospital
F A/B2
Bugs & drugs in ankle biters : antibiotic choice in paediatric hospital infections
Sarah Thompson, Consultant Microbiologist, Sheffield Children’s Hospital
F A/B3
Do you need a pharmacist when there is Toxbase®?
Astrid Gerrard, Clinical Pharmacist, PICU, Birmingham Children’s Hospital
I A/B4
NHS Commissioning: Implications for High Cost Medicines in Paediatrics
Judith Gregory, Lead Pharmacist - High Cost Medicines, Nottingham University Hospitals NHS Trust (in collaboration
with NHS England and Nottinghamshire CCGs)
I A/B5
Self / Parent / Carer administration
Elizabeth Upton, Paediatric Pharmacist, Nottingham University Hospitals NHS Trust
A A/B6
Inspiring future pharmacy leaders
Bianca Davies, Prescribing Support Pharmacy Technician, NHS Portsmouth Clinical Commissioning Group
3.30pm
Refreshments, exhibition & posters
4.00pm
Repeated Parallel sessions as above
(Choose to attend one)
4.50pm
Close of day
7.30pm
Annual Conference Dinner & Dance
Join the
conversation
#NPPG2014
Sunday 9 November
9.30am
F W1
F W2
I W3
I W4
I W5
Title:Name:
Surname:
Job title:
Workshops
Employing organisation:
(90 minutes in length, choose to attend one)
Address for correspondence:
Consultation skills for pharmacy practice
standards: Making it relevant for children and
adolescents
Chris Cutts, Professor of Professional
Development and Practice Director, Manchester
Pharmacy School
Individualised and standardised neonatal
TPN. Can you do both simultaneously?
Neil Caldwell, Consultant Pharmacist, Children’s
Services, Wirral University Teaching Hospital NHS
Foundation Trust
Paediatric Renal disease
Andrew Wignell, Senior Paediatric Pharmacist,
Nottingham University Hospital NHS
What pharmacists need to know about
looking after children with an Inherited
Metabolic Disorder
Satwinder Chana, Birmingham Children’s Hospital
Dr Saikat Santra, Consultant Paediatrician in
Inherited Metabolic Diseases
How to assess liver function in children and
what to do about it!
Penny North-Lewis, Paediatric Liver Pharmacist,
Leeds General Infirmary
11.00am
Comfort break
11.15am
Chairs’ Comments
Penny North-Lewis, Chair, NPPG
11.20am
Booking form
NPPG update and AGM – the last 12 months
Penny North-Lewis, Chair, NPPG
11.35am
NPPG Research grants – Final Feedback
Clare Nash
11.50am
Keynote 3 – Brain tumour management
and recent medical innovations
Dr David Walker, Professor of Paediatric
Oncology, Children’s Brain Tumour Research
Centre, Faculty of Medicine and Health Sciences,
University of Nottingham
12.30pm
Specials Products – 2014 Awards for
presentations, posters and innovations
12.40pm
End of Conference
‘This meeting has been supported by Chiesi through
the purchase of exhibition trade space’
Postcode:
Tel:
Email:
Prices for 2014
Type
Before 4th Sept 2014 After 4th Sept 2014
Full conference (single occupancy for two nights)
NPPG member
£445
£495
Non-member (NHS/Public)
£545
£495
Non-member (Private sector)
£600
£550
Full conference (twin room, for two people, price per person)
NPPG member
£400
£370
Non-member (NHS/Public)
£425
£475
Non-member (Private sector)
£500
£550
Full conference (no accommodation)
NPPG member
£275
£300
Non-member (NHS/Public)
£305
£335
Non-member (Private sector)
£450
£500
Two day conference (Friday accommodation, and Saturday dinner ticket)
NPPG member
£375
£325
Non-member (NHS/Public)
£400
£450
Non-member (Private sector)
£450
£500
Saturday only (no dinner ticket)
NPPG member
£99
£119
Non-member (NHS/Public)
£119
£139
Non-member (Private sector)
£169
£149
Undergraduate students/Pre-registration Pharmacist full conference,
no accommodation
Without dinner
£140
£140
With 1 dinner ticket
£175
£175
Additional dinner ticket - I wish to purchase
tickets @ £35 each.
Please pre-book your sessions
Friday – Discussion Groups
(please select two)
1
2
3
4
5
1
2
3
4
5
Saturday – Parallel sessions
(please chose one from each A & B)
A1
A2
A3
A4
A5
A6
B1
B2
B3
B4
B5
B6
W4
W5
Sunday – Workshops
(please chose one)
W1
W2
W3
Payment details
Cheque
I enclose a cheque made payable to NPPG Conference for the sum
of £____________
Credit Card
The venue
Please debit my MasterCard/Visa/Maestro for the sum of
£____________
Card no:
/
Expiry date:
/
/
Issue no:
Security no:
Invoice
Please send me an invoice for the sum of £____________
Invoice: you may ONLY select this option if you include a valid
Purchase Order number from your employer as proof that payment
will be made. Bookings cannot be processed without this.
Purchase order number:
East Midlands Conference Centre (EMCC)
The East Midlands Conference Centre is located just two miles from
the centre of Nottingham and offers excellent, flexible facilities for
conferences, exhibitions and events including a 850 seat auditorium
and numerous breakout rooms. For further information please visit
www.deverevenues.co.uk
Name for invoice:
Address for invoice:
Postcode:
N.B. Invoices will be sent via email.
Terms and conditions:
1. The organiser of the
NPPG 20th Annual
Conference and
Exhibition is Profile
Productions Ltd,
Exchange Plaza, 58
Uxbridge Road, London
W5 2ST.
2. Registrations can
only be accepted on
receipt of a completed
registration form.
Completion of this
registration form
constitutes a legally
binding agreement
and you must sign,
agreeing to the terms
and conditions, in order
for your booking to be
processed.
3. Your place is not
guaranteed until
you have received
confirmation from Profile
Productions Ltd.
4. Confirmation will be
sent to you within 14
working days of receiving
your booking.
5. Profile Productions
Ltd. cannot be held
responsible should your
registration form not be
received.
6. If you have not heard
from us 14 working
days after sending your
completed form, or 14
working days before
the start date of the
conference, it is your
responsibility to contact
us to ensure your place
is booked.
7. All invoices should be
paid within 21 days of the
invoice date and MUST
be paid prior to the
conference in all cases.
Failure to do so may
result in your place being
cancelled.
8. Any delegates
registering within 28
days of the start of
the conference MUST
include valid credit
card details on the
registration form.
9. The delegate is
responsible for ensuring
payment to Profile
Productions Ltd.
has been made. Any
delegates arriving at
the conference without
payment having been
made will be asked
to provide credit card
details as a guarantee of
payment; refusal to do
this may result in entry
to the conference not
being permitted.
10. Full conference
registration fees include
VAT at the prevailing
rate, complimentary
refreshments, Friday
Supper, Saturday lunch,
Saturday dinner and
conference materials.
11. Those booking
‘Saturday only’ tickets,
please note these do
not include a dinner
ticket, these need to be
purchased separately.
12. Cancellations will
only be accepted in
writing. Cancellations
received on or prior to
10th October 2014 will
be refunded subject to
a £25 administration
fee. Cancellations
received after 10th
October 2014 will not
be refunded. However,
substitute delegates will
be accepted at any time
but please notify the
organisers in writing of
any name changes.
13. Any delegate
registered to attend who,
for whatever reason, may
not be able to attend the
conference, is still liable
for payment as per the
cancellation policy in
item 12.
14. Attendance fees
will not be refunded in
the event of threat of
war, terrorist or other
circumstances outside of
the organisers’ control.
15. There will be
photography and video
production taking place
during the conference
and the resulting
images may be used for
promotional purposes.
Delegates who do not
wish their images to be
included in this material
should contact the
organisers by email at
admin@nppg.org.uk
prior to the event.
I have read and agreed to the terms and conditions as
detailed above and confirm that payment will be made before
the start of the conference.
Signed
Date
Accommodation
Adjacent to the EMCC is the newly built Orchard Hotel. With over 200
bedrooms, this eco-friendly hotel has been designed to maximise the
use of natural daylight and features rooftop terraces, floor-to-ceiling
windows and unique contemporary decor throughout.
By car
Leave the M1 motorway at junction 25 and follow the A52 signposted
to Nottingham. After approximately 4.4 miles turn right at the
roundabout (Toby Carvery) onto the A6464 Woodside Road. Turn left
at the next roundabout to enter the University of Nottingham’s West
Entrance. The EMCC is situated on Beeston Road, which is the main
loop road through the campus.
By rail
The nearest stations to the EMCC are Beeston Station and
Nottingham. There are over 30 direct trains that travel between St
Pancras and Nottingham on a daily basis. Visit www.nationalrail.co.uk
or phone 08457 484950 for further information. Alight at Beeston,
which is the main stop for the University campus.
By air
From East Midlands Airport, the EMCC is just 14 miles away via the
M1 North leaving at junction 25 and following the A52. There is also
the regular Skylink Nottingham bus, leaving directly from the airport
directed to Broad Marsh Bus Station. Alight at Beeston, which is the
stop for the main University campus.
Conference organisers:
Profile Productions Ltd
Exchange Plaza,
58 Uxbridge Road,
London W5 2ST
t: +44 (0)20 3725 5840
f: +44 (0)844 507 0578
e: admin@nppg.org.uk
w: www.profileproductions.co.uk
NPPG 20th Annual Conference and Exhibition
7-9 November 2014 East Midlands Conference Centre, Nottingham
Overviews
Discussion groups
1. Medicines information update
This group is aimed at those interested in the role of the NPPG
information officer.
Session objectives:
Provide information on the role of the Information Support Service
to NPPG members and to external organisations
Provide an opportunity to input ideas for future topics to be
undertaken by the Information Support Service for NPPG members
Provide an opportunity to network and share views on information
needs surrounding common prescribing issues.
Learning outcomes
By the end of the session you will:
Have an understanding of the role of the Information Support
Service to NPPG
Have an understanding of the work undertaken so far by the
Information Support Service
Have awareness of possible ways forward for the Information
Support Service.
.
Parallel session
F A/B1 Diagnosis and management of Gastro-oesophageal
reflux disease GORD in children
Understand the Pathophysiology and natural history related to
GORD in children
Differentiate terms for reflux-related symptoms and signs in children
To be able to review diagnostic approaches in children with GORD
To gain awareness of various treatment approaches in children
with GORD.
F A/B2 Bugs & drugs in ankle biters: antibiotic choice in
paediatric hospital infections
Key learning points:
By the end of the session attendees will be able to:
list the considerations critical for selecting an appropriate
antibiotic(s) for complex infections
critically review the antibiotics available for treatment of resistant
organisms in hospital infections
think like a Microbiologist!
F A/B3 Do you need a pharmacist when there is Toxbase®?
This interactive session will focus on a case-based discussion on
the pharmacological, pharmaceutical, and logistical aspects of
managing overdose in paediatric patients. This workshop is aimed at
pharmacists working at all levels of experience who provide clinical
services to paediatric patients including on-call services.
The objectives of the workshop are:
To be able to clinically appraise Toxbase® guidance in a paediatric
context
To gain awareness of antidote availability across the UK
To be able to advice on administration of antidote therapy in
paediatric patients
To able to effectively monitor antidote therapy administered to
paediatric patients.
The workshop will be presented by Astrid Gerrard, Kevin Bazaz
and Rhian Isaac – Clinical Pharmacists Paediatric Intensive Care,
Birmingham Children’s Hospital NHSFT.
2. Update on national developments and initiatives in
paediatric pharmacy 2014
This group is aimed at those interested in the national issues relevant
to paediatric pharmacy.
This session will include updates on national developments such
as specialist commissioning, RCPCH faculty, Children and Young
Person’s Outcome Forum, Safety initiatives and much, much more!
3. Developing MEDUSA for paediatrics
This group is aimed at those interested in NPPG sponsored progress
with paediatric monographs within Medusa.
In a recent survey, 120 out of 145 UK/Irish hospitals told us that
they use the Medusa “injectable Medicines Guide”, which is an
NHS supported website for information about the administration
of injectable medicines. 93% of responders treat children under 18
years old. Although 30% responders said that they had developed
their own paediatric guidelines for IV administration in children aged
1-16yrs, another 30% were using their adult guidelines to treat
children. The Medusa “Injectable Medicines Guide” is now used at
ward level in 60% of responding centres. Monographs are written by
UK medicines information pharmacists, yet paediatric pharmacists
have rarely been involved in the process before now.
I A/B4 NHS Commissioning: Implications for High Cost
Medicines in Paediatrics
The session will aim to outline current Commissioning structures
within the NHS and resulting funding flows for High Cost Medicines
in Paediatrics. There will be opportunity to discuss practical aspects
of applying for funding and setting up homecare services.
At the end of the session participants should be able to:
Explain the difference between cohort and individual funding
requests and know what process to follow in each scenario
List key elements crucial to the introduction of a successful
homecare delivery service.
I A/B5 Self / Parent / Carer administration
The learning objectives of this session are that participants will:
Discuss the advantages and disadvantages of self / parent /
carer administration
Identify potential barriers to implementation
Consider options to overcome barriers to implementation.
A A6/B6 Inspiring future pharmacy leaders
The Inspiring future pharmacy leaders workshop aims to encourage
future leaders in pharmacy to explore the challenges and rewards
of leadership and inspire them to develop their leadership skills and
behaviours. On completion of all aspects of this learning programme
you should be able to:
assess your leadership strengths and identify areas for
improvement
identify your leadership style and discuss the strengths and
limitations with your peers
describe the domains of the Leadership Competency Framework
for Pharmacy Professionals and select the competencies you want
to develop
identify the resources and support available that can assist your
personal leadership development.
Join the
conversation
#NPPG2014
In September 2013, a joint project between NPPG and the Medusa
was launched to improve the quality and accessibility of paediatric
information within the Medusa website.
4. RPS Faculty
This group is aimed at those interested in what Faculty
membership entails.
This session will involve:
Outline of the project – development over the past year
Where we are at now – a demonstration of the website and the
ability to “localise” monographs
Plans for the future and the way forward
Specific challenges – the displacement value debate and others.
Round table discussion will offer an opportunity to share ideas about:
How Faculty membership can benefit your practice
Building your Faculty portfolio
Using Faculty tools for your development- including
- Advanced Pharmacy Framework
- Expert Practice Professional Curricula
Preparing yourself for Faculty assessment
Opportunity to share experiences and discuss how NPPG & RPS
can support you.
We can also discuss any particular issues members have had e.g.
when writing monographs, with content on the website, or how this
resource is used in practice. Please send any queries in advance to
Jennifer.Haylor@UHBristol.nhs.uk, or just bring them along. For more
information see www.medusa.wales.nhs.uk or www.injguide.nhs.uk
(user name IVgdemo, password bolus7)
Workshops
F W1 Consultation skills for pharmacy practice standards:
Making it relevant for child and adolescents
Effective consultation skills lie at the heart of patient-centred care.
CPPE and Health Education England has identified this area of skills
development as a priority for the pharmacy profession, leading to
the development of a set of practice standards for consultation skills
that outline the knowledge, skills and behaviours expected of all
pharmacy professionals in a patient-facing role.
How effective are your patient-consultations with children and
adolescent? Are you confident you take a patient-centred approach?
This workshop introduces you to the Consultation skills for pharmacy
practice learning and development programme which provides a
six-step pathway of tools and resources to support you in working
towards the practice standards and developing your practice. It
challenges you to put your current skills under the microscope and
take them on a ‘test drive’.
On completion of all aspects of this learning programme you should
be able to:
recognise your professional responsibility to reflect on and
develop your consultation skills, by working towards the new
practice standards
explain the concept of patient-centred care and identify methods
of integrating this into your practice with children and adolescents
apply a reflective tool to assess your ability to consult effectively
with patients and identify key areas on which to build your expertise
access tools and resources from the Consultation skills for
pharmacy practice learning and development programme to support
you in moving your practice forward
take your current skills on a ‘test drive’ by taking part in role play
scenarios with pharmacy colleagues in a safe environment.
F W2 Individualised and standardised neonatal TPN. Can
you do both simultaneously?
This session is aimed at foundation level practitioners who see
neonates receiving PN. It will focus on short term management within
an everyday district general hospital. You may wonder, what can I do?
Before attending consider, what does your team do that is exemplary?
Come prepared to defend what happens in your practice base.
During the session we will explore what could you do differently? At
the end of the session you will leave with good practice points, from
colleagues, that you can implement back at base. Non neonatal or
non nutrition pharmacists may find it interesting and useful.
5. Medicines for Children Research Network (MCRN) – how
can we support you?
This group is aimed at those interested in undertaking research in
paediatric pharmacy or paediatric medicines.
I W3 Paediatric Renal disease
This interactive session will be aimed at intermediate level
pharmacists and we will do a bit of quick revision then work through
some cases of children with renal disease. There are often more
questions than answers, so there will be an opportunity to discuss
cases you have seen and problems you have encountered.
At the end of the session you should be able to:
Determine the level/type of renal dysfunction in a child and what
the implications might be for drug dosing
Identify common drug causes of Acute Kidney Injury and ways in
which damage can be minimised or avoided
Describe the key features of Nephrotic Syndrome and outline the
management of this condition.
I W4 What pharmacists need to know about looking after
children with an Inherited Metabolic Disorder
The session will be aimed at pharmacists who have been looking
after patients with an inherited metabolic disorder (IMD), and those
who require an introduction to this rare disease area. We will cover
some basic concepts required to understand some of the main
rare conditions that we see in hospital, and how to manage them.
This will be through some interactive case studies of children with
various IMD’s.
At the end of the session you should be able to:
Have an awareness of the common metabolic conditions in
neonates and paediatrics that we see presented in hospital.
Understand how drug therapy is used to manage some of the
main conditions.
Understand some of the issues surrounding the supply of
medications for rare conditions.
I W5 How to assess liver function in children and what to do
about it!
This session will be aimed at intermediate level pharmacists and
we will do a bit of quick revision then work through some cases of
children with various types of liver disease. There will be plenty of
opportunity for you to discuss problems you’ve come across and to
ask questions.
At the end of the session you should be able to:
Interpret LFTs, other investigation results, signs and symptoms to
determine the type and extent of a child’s liver dysfunction
Decide what the implications are for drug choice and dose.